Ra Capital Management, L.P. Tyra Biosciences, Inc. Put Options Transaction History
Ra Capital Management, L.P.
- $6.17 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TYRA
# of Institutions
112Shares Held
43.1MCall Options Held
3.8KPut Options Held
6K-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$53.6 Million97.27% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$52.3 Million89.47% of portfolio
-
Nextech Invest Ag4.06MShares$52 Million10.51% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$50.6 Million2.05% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$25.5 Million4.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $538M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...